The Mechanism Underlying the Analgesic Effect of the Music of IBS Pain
Launched by YALE UNIVERSITY · Nov 25, 2024
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how listening to music can help reduce pain and discomfort in people with Irritable Bowel Syndrome (IBS). The study aims to understand how music might affect pain, stress levels, and the balance of bacteria in the gut. Researchers will also test a new wearable device that tracks how music impacts pain in a person's daily life.
To participate, you need to be between 18 and 50 years old, speak and read English, and have been diagnosed with IBS. You should be experiencing moderate pain at least four days a week. If you decide to join, you will participate in a 4-week program where you'll listen to music for 20 minutes each day and attend two lab visits. The trial is not yet open for recruitment, so keep an eye out for updates if you're interested!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • aged between 18 and 50 years old,
- • can speak and read English,
- • having a confirmed diagnosis of IBS from a healthcare provider,
- • having experienced moderate pain (≥3 out of 10 on a numeric rating scale) at least four days a week for the past three months,
- • be willing to participate in a 4-week intervention and attend two lab visits, and
- • having daily access to an internet-enabled device for MBI.
- Exclusion Criteria:
- • having a severe psychiatric disorder requiring inpatient treatment in the past six months,
- • regularly using opioids or illicit substances, or have used probiotics or antibiotics within two weeks prior to enrollment,
- • having celiac disease, inflammatory bowel disease, or a history of major gastrointestinal surgery,
- • concurrently participate in another IBS-related intervention study.
About Yale University
Yale University, a prestigious Ivy League institution located in New Haven, Connecticut, is renowned for its commitment to advancing medical research and clinical innovation. With a rich history of academic excellence and a robust infrastructure for scientific inquiry, Yale serves as a leading sponsor for clinical trials aimed at improving patient care and developing new therapeutic approaches. The university's multidisciplinary teams of researchers and clinicians collaborate to conduct rigorous and ethical studies, leveraging cutting-edge technologies and methodologies to address critical health challenges. Through its dedication to fostering an environment of inquiry and discovery, Yale University plays a pivotal role in translating research findings into clinical practice, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New Haven, Connecticut, United States
Patients applied
Trial Officials
Weizi Wu, PhD
Principal Investigator
Yale School of Nursing
Xiaomei Cong, PhD
Principal Investigator
Yale School of Nursing
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported